| Literature DB >> 18174196 |
Robert W Burgoyne1, Darrell H S Tan.
Abstract
Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities, one of the Achilles' heels of HAART. This article reviews research findings on treatment and QOL outcomes a decade into the HAART era.Entities:
Mesh:
Year: 2008 PMID: 18174196 DOI: 10.1093/jac/dkm499
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790